This legislation, if passed, would require Medicare to cover obesity medications, which could open the door for broader insurance coverage
The idea is straightforward: semaglutide handles the GLP-1 pathway, while cagrilintide adds amylin-family satiety and post-meal glucose biology
Evidence suggests that prolonged or excessive use of semaglutide medications, including Ozempic, can lead to gastroparesis and other significant side effects
Acknowledgements Work in the authors laboratory has been supported by grants from the NIH (DK57539, DK58282, DK64819 and DK63608-Columbia Diabetes Research Center)
Ultimately, whether microdosing becomes mainstream will depend on future clinical evidence
Still, some people do experience side effects of glutathione, if only temporarily